---
figid: PMC4005015__nihms239986f8
figlink: /pmc/articles/PMC4005015/figure/F8/
number: Fig. 8
caption: The hyperglycemic hexosamine pathway starting from the glycolytic intermediate,
  F-6-P, which is converted by GFAT to glucosamine-6-P and eventually to UDPGlcNAc,
  an O-linked GlcNAc. Intracellular glycosylation by adding GlcNAc moieties to serine
  and threonine residues of proteins (e.g. transcription factors) is catalysed by
  OGT. Increased glycosylation of transcription factors, such as Sp1, AP2 and CREB,
  often at phosphorylation sites, increases the expression of cytokines and enzymes,
  including TGF- β 1, PAI-1, and glycosyltransferase. In addition, AGEs can exert
  cellular effects by increasing a-series ganglioside levels to inhibit retinal pericyte
  cell proliferation. Other cytoplasmic proteins are also subjects to dynamical modification
  by hyperglycemia-induced O-linked GlcNAc, such as the inhibition of eNOS activity
  by O-acetylglucosaminylation at the Akt site of the eNOS protein and activations
  of various PKC isoforms by glucosamine without membrane translocation.
pmcid: PMC4005015
papertitle: DIETARY HYPERGLYCEMIA, GLYCEMIC INDEX AND METABOLIC RETINAL DISEASES.
reftext: Chung-Jung Chiu, et al. Prog Retin Eye Res. ;30(1):18-53.
pmc_ranked_result_index: '122304'
pathway_score: 0.9620674
filename: nihms239986f8.jpg
figtitle: DIETARY HYPERGLYCEMIA, GLYCEMIC INDEX AND METABOLIC RETINAL DISEASES
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4005015__nihms239986f8.html
  '@type': Dataset
  description: The hyperglycemic hexosamine pathway starting from the glycolytic intermediate,
    F-6-P, which is converted by GFAT to glucosamine-6-P and eventually to UDPGlcNAc,
    an O-linked GlcNAc. Intracellular glycosylation by adding GlcNAc moieties to serine
    and threonine residues of proteins (e.g. transcription factors) is catalysed by
    OGT. Increased glycosylation of transcription factors, such as Sp1, AP2 and CREB,
    often at phosphorylation sites, increases the expression of cytokines and enzymes,
    including TGF- β 1, PAI-1, and glycosyltransferase. In addition, AGEs can exert
    cellular effects by increasing a-series ganglioside levels to inhibit retinal
    pericyte cell proliferation. Other cytoplasmic proteins are also subjects to dynamical
    modification by hyperglycemia-induced O-linked GlcNAc, such as the inhibition
    of eNOS activity by O-acetylglucosaminylation at the Akt site of the eNOS protein
    and activations of various PKC isoforms by glucosamine without membrane translocation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L1
  - GFPT1
  - CREB3L3
  - PRKCQ
  - TGFB1
  - PRKCA
  - PRKD3
  - SP1
  - PRKCG
  - ATF1
  - PRKCD
  - CREB3L2
  - PRKCI
  - PRKCZ
  - OGT
  - PRKCE
  - CREB5
  - NOS3
  - PRKCB
  - SERPINE1
  - PRKCH
  - CREM
  - TFAP2A
  - CREB1
  - ATF2
  - CREB3L4
  - CREB3
  - Ceramide
  - Glucosamine-6-P
  - Glucose
  - Pyruvate
genes:
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: GFAT
  symbol: GFAT
  source: hgnc_alias_symbol
  hgnc_symbol: GFPT1
  entrez: '2673'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: Sp1,
  symbol: SP1
  source: hgnc_symbol
  hgnc_symbol: SP1
  entrez: '6667'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: OGT
  symbol: OGT
  source: hgnc_symbol
  hgnc_symbol: OGT
  entrez: '8473'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PAI-1
  symbol: PAI1
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINE1
  entrez: '5054'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: AP2,
  symbol: AP-2
  source: hgnc_alias_symbol
  hgnc_symbol: TFAP2A
  entrez: '7020'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: Sp1,AP2,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
- word: Glucosamine-6-P
  source: MESH
  identifier: D005944
- word: Glucose
  source: MESH
  identifier: D005947
- word: Pyruvate
  source: MESH
  identifier: D011773
diseases: []
---
